HB Wealth Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,280
| Closed | -$406K | – | 937 |
|
|
2024
Q1 | $406K | Hold |
4,280
| – | – | 0.01% | 555 |
|
|
2023
Q4 | $382K | Buy |
4,280
+200
| +5% | +$17.9K | 0.01% | 526 |
|
|
2023
Q3 | $298K | Buy |
4,080
+688
| +20% | +$50.2K | ﹤0.01% | 571 |
|
|
2023
Q2 | $282K | Buy |
3,392
+52
| +2% | +$4.33K | ﹤0.01% | 562 |
|
|
2023
Q1 | $255K | Sell |
3,340
-52
| -2% | -$3.96K | ﹤0.01% | 584 |
|
|
2022
Q4 | $282K | Buy |
+3,392
| New | +$282K | 0.01% | 534 |
|
|
2022
Q1 | – | Sell |
-1,973
| Closed | -$221K | – | 620 |
|
|
2021
Q4 | $221K | Buy |
+1,973
| New | +$221K | ﹤0.01% | 466 |
|